Efficacy of artemether-lumefantrine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso, 2020–2021

Continued low uncorrected efficacy of AL was observed in all sites, with one half to one third of children returning to the clinic with repeat infection within 28 days. PCR-corrected efficacy was at or below 90% for AL. AS-PYR and DP were associated with low rates of recurrent parasitaemia suggesting a potential for implementing a multiple first-line therapy approach with non-AL ACT. This approach will allow to preserve future use of lumefantrine and improve patient outcomes.

Authors

Institutions

Publication Details

Journal
Malaria Journal
Published
2025-12-01
DOI
https://doi.org/10.1186/s12936-025-05693-z
Primary Topic
Malaria Research and Control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of artemether-lumefantrine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso, 2020–2021

Innocent Valéa, Rene Kinda, Adama Gansané, Casimir Tarama et al.
Malaria Journal
Malaria Research and Control
article

Efficacy of artemether-lumefantrine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso, 2020–2021

Innocent Valéa, Rene Kinda, Adama Gansané, Casimir Tarama, Salif Sombié, Jessica N. McCaffery, Toussaint Rouamba, Halidou Tinto, Edwin Pierre-Louis, Stefano Rosillo, Leah F. Moriarty, Jehan Ahmed, Moussa Lingani, Marko Bajic, Christian S. Kompaore, Lubbe Wiesner, Dhruviben Patel, Henri Somé, Mateusz M. Pluciński, Siaka Débé, Charlotte Eddis, Aladari Sagnon, A. Ganou, Gauthier Tougri, Massa Achille Bonko, Breanna Horton, Farida Tiendrebeogo, Alfred J. Kahn, C. C. Kennedy, Veronika R. Laird, Seraphine Kiendrebeogo
article en

Abstract

Continued low uncorrected efficacy of AL was observed in all sites, with one half to one third of children returning to the clinic with repeat infection within 28 days. PCR-corrected efficacy was at or below 90% for AL. AS-PYR and DP were associated with low rates of recurrent parasitaemia suggesting a potential for implementing a multiple first-line therapy approach with non-AL ACT. This approach will allow to preserve future use of lumefantrine and improve patient outcomes.

Malaria JournalVol. 25(1)
Oak Ridge Associated Universities (US), Centers for Disease Control and Prevention (US), Emory University (US), University of Cape Town (ZA), U.S. President's Malaria Initiative (US), The Centers (US), Centre National de Recherche et de Formation sur le Paludisme (BF), Institut de Recherche en Sciences de la Santé (BF)
Openalex Percentile: Top 52%
Malaria Research and Control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.